TY  - GEN
AU  - Moore,F D
AU  - Schoof,D D
AU  - Rodrick,M
AU  - Eberlein,T J
TI  - The systemic complement activation caused by interleukin-2/lymphokine-activated killer-cell therapy of cancer causes minimal systemic neutrophil activation
SN  - 0020-7136
PY  - 1991///1121
KW  - Chemotaxis, Leukocyte
KW  - drug effects
KW  - Complement Activation
KW  - Complement System Proteins
KW  - analysis
KW  - Humans
KW  - In Vitro Techniques
KW  - Interleukin-2
KW  - therapeutic use
KW  - Killer Cells, Lymphokine-Activated
KW  - N-Formylmethionine Leucyl-Phenylalanine
KW  - pharmacology
KW  - Neoplasms
KW  - blood
KW  - Neutrophils
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1002/ijc.2910490405
ER  -